Skip to main content
Premium Trial:

Request an Annual Quote

The Downside: Then You Have to Label the Patients "GMO"

This article in the Guardian describes a DNA-based vaccine for multiple sclerosis that's gone through in human trials and "has been declared a success by doctors in America after tests on patients revealed signs that their condition had improved," according to the story. The vaccine contains DNA responsible for producing myelin, which serves to prevent the immune system from going haywire and causing MS.